145 related articles for article (PubMed ID: 8617576)
1. Phase II trial of gallium nitrate, amonafide and teniposide in metastatic non-small cell lung cancer. An Eastern Cooperative Oncology Group study (E2588).
Chang AY; Tu ZN; Smith JL; Bonomi P; Smith TJ; Wiernik PH; Blum R
Invest New Drugs; 1995; 13(2):137-41. PubMed ID: 8617576
[TBL] [Abstract][Full Text] [Related]
2. A randomized phase II trial of amonafide or trimetrexate in patients with advanced non-small cell lung cancer. A trial of the North Central Cancer Treatment Group.
Gesme DH; Jett JR; Schreffler DD; Su JQ; Mailliard JA; Foley JF; Krook JE; Maksymiuk AW; Hatfield AK; Ebbert LP
Cancer; 1993 May; 71(9):2723-6. PubMed ID: 8385564
[TBL] [Abstract][Full Text] [Related]
3. Amonafide: An active agent in the treatment of previously untreated advanced breast cancer--a cancer and leukemia group B study (CALGB 8642).
Costanza ME; Berry D; Henderson IC; Ratain MJ; Wu K; Shapiro C; Duggan D; Kalra J; Berkowitz I; Lyss AP
Clin Cancer Res; 1995 Jul; 1(7):699-704. PubMed ID: 9816035
[TBL] [Abstract][Full Text] [Related]
4. An ECOG phase II study of amonafide in unresectable or recurrent carcinoma of the head and neck (PB390). Eastern Cooperative Oncology Group.
Leaf AN; Neuberg D; Schwartz EL; Wadler S; Ritch PS; Dutcher JP; Adams GL
Invest New Drugs; 1997; 15(2):165-72. PubMed ID: 9220297
[TBL] [Abstract][Full Text] [Related]
5. A phase II trial of amonafide in patients with endometrial cancer: a Gynecologic Oncology Group Study.
Asbury R; Blessing JA; Reid GC; McGuire WP
Am J Clin Oncol; 1998 Aug; 21(4):406-7. PubMed ID: 9708643
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of amonafide for the treatment of advanced, hormonally refractory carcinoma of the prostate. A Southwest Oncology Group study.
Marshall ME; Blumenstein B; Crawford ED; Thompson IM; Craig JB; Eisenberger M; Ahmann F
Am J Clin Oncol; 1994 Dec; 17(6):514-5. PubMed ID: 7977172
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of amonafide: results of treatment and lessons learned from the study of an investigational agent in previously untreated patients with extensive small-cell lung cancer.
Evans WK; Eisenhauer EA; Cormier Y; Ayoub J; Wierzbicki R; Laberge F; Shepherd FA
J Clin Oncol; 1990 Mar; 8(3):390-5. PubMed ID: 2155309
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of amonafide in the treatment of patients with advanced squamous cell carcinoma of the head and the neck. An Illinois Cancer Center study.
Rosen F; Vokes EE; Lad T; Kies M; Wade J; Kilton LJ; Blough R; French S; Mullane M; Benson AB
Invest New Drugs; 1995; 13(3):249-52. PubMed ID: 8729954
[TBL] [Abstract][Full Text] [Related]
9. Amonafide in patients with leiomyosarcoma of the uterus: a phase II Gynecologic Oncology Group study.
Asbury R; Blessing JA; Buller R; Malfetano JH; Walker J; Sevin BU
Am J Clin Oncol; 1998 Apr; 21(2):145-6. PubMed ID: 9537200
[TBL] [Abstract][Full Text] [Related]
10. Amonafide treatment of refractory esophageal cancer. A Southwest Oncology Group study.
Poplin E; Fleming T; MacDonald JS; Eisenberg P; Fisher RI; Conrad ME
Invest New Drugs; 1993 Feb; 11(1):47-51. PubMed ID: 8349435
[TBL] [Abstract][Full Text] [Related]
11. Study of either ifosfamide or teniposide compared to a standard chemotherapy for extensive disease small cell lung cancer: an Eastern Cooperative Oncology Group randomized study (E1588).
Ettinger DS; Finkelstein DM; Ritch PS; Lincoln ST; Blum RH;
Lung Cancer; 2002 Sep; 37(3):311-8. PubMed ID: 12234701
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of amonafide in central nervous system tumors: a Southwest Oncology Group study.
Taylor SA; Rankin C; Townsend JJ; Craig JB; Vance RB; Solank DL; Brown TD; Jaeckle K;
Invest New Drugs; 2002 Feb; 20(1):113-5. PubMed ID: 12003186
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of amonafide in patients with stage III and IV non-small-cell lung cancer.
Berger MZ; Kris MG; Gralla RJ; Marks LD; Potanovich LM; Dimaggio JJ; Heelan RT
Am J Clin Oncol; 1991 Apr; 14(2):124-6. PubMed ID: 1851387
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of gallium nitrate in previously treated patients with small cell lung cancer.
Baselga J; Kris MG; Scher HI; Phillips M; Heelan RT
Invest New Drugs; 1993 Feb; 11(1):85-6. PubMed ID: 8394297
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of amonafide in advanced and recurrent sarcoma patients.
Perez RP; Nash SL; Ozols RF; Comis RL; O'Dwyer PJ
Invest New Drugs; 1992 Jul; 10(2):99-101. PubMed ID: 1500272
[TBL] [Abstract][Full Text] [Related]
16. Phase I clinical investigation of amonafide.
Saez R; Craig JB; Kuhn JG; Weiss GR; Koeller J; Phillips J; Havlin K; Harman G; Hardy J; Melink TJ
J Clin Oncol; 1989 Sep; 7(9):1351-8. PubMed ID: 2549205
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of amonafide in patients with advanced metastatic or recurrent endometrial adenocarcinoma. A Southwest Oncology Group study.
Malviya VK; Liu PY; O'Toole R; Alberts DS; Surwit E; Rosenoff S; Ward JH; Yu A; O'Sullivan J; Craig JB
Am J Clin Oncol; 1994 Feb; 17(1):37-40. PubMed ID: 8311005
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of amonafide (nafidamide, NSC 308847) in advanced colorectal cancer.
O'Dwyer PJ; Paul AR; Hudes GR; Walczak J; Ozols RF; Comis RL
Invest New Drugs; 1991 Feb; 9(1):65-7. PubMed ID: 2026485
[TBL] [Abstract][Full Text] [Related]
19. A Gynecologic Oncology Group phase II study of amonafide (NSC 308847) in epithelial ovarian cancer.
Asbury RF; Blessing JA; Look KY; Clarke-Pearson D; Homesley HD
Am J Clin Oncol; 1993 Dec; 16(6):529-31. PubMed ID: 8256772
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of amonafide in advanced pancreas cancer. A Southwest Oncology Group study.
Leichman CG; Tangen C; Macdonald JS; Leimert T; Fleming TR
Invest New Drugs; 1993; 11(2-3):219-21. PubMed ID: 8262735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
